Biomarkers of Osteoarthritis: A Review of Recent Research Progress on Soluble Biochemical Markers, Published Patents and Areas for Future Development

Osteoarthritis (OA) is the most common type of arthritis in humans and animals. It is a major cause of pain and disability and has significant consequences for public health. The burden of OA is expected to increase with ageing of the population and the present obesity epidemic. Therefore, there is an acute need for reliable biomarkers that can facilitate earlier diagnosis of OA, and inform the prognosis, monitoring and therapeutic strategies for chronic forms of this disease. However, the field is hampered by a lack of reliable, quantifiable, easily measured biomarkers that provide an earlier diagnosis of OA, inform on the prognostic of the disease and monitor and predict the responses of a patient to a therapeutic modality. Biomarkers of tissue turnover in joints have the capacity to reflect disease relevant biological activity and provide information that may be useful diagnostically and therapeutically, potentially enabling a more rational and personalised approach to healthcare management. In this paper, we review recent progress in the area of OA biochemical marker research. We hope that this review stimulates further research into OA biomarkers and contributes to the development of new and innovative tests for early disease diagnosis, facilitating individualised treatment and improving clinical outcome. We also review a selected number of recent patents relevant to the area of OA biomarkers highlighting areas for commercial development.

[1]  A R Poole,et al.  Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis OARSI FDA Osteoarthritis Biomarkers Working Group , 2011 .

[2]  P. Clegg,et al.  Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis. , 2010, Veterinary journal.

[3]  P. Clegg,et al.  Biomarkers of cartilage turnover. Part 2: Non-collagenous markers. , 2010, Veterinary journal.

[4]  A. Mobasheri,et al.  Identification, validation and qualification of biomarkers for osteoarthritis in humans and companion animals: mission for the next decade. , 2010, Veterinary journal.

[5]  W. Lems,et al.  Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. , 2010, Osteoarthritis and cartilage.

[6]  D. Burstein,et al.  A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials. , 2010, Current drug targets.

[7]  J. Willeit,et al.  Risk prediction for severe osteoarthritis , 2010, Annals of the rheumatic diseases.

[8]  Y. Henrotin,et al.  Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis. , 2010, Osteoarthritis and cartilage.

[9]  M. Karsdal,et al.  Biochemical markers of joint tissue turnover. , 2010, Assay and drug development technologies.

[10]  M. Karsdal,et al.  Application of biochemical markers in development of drugs for treatment of osteoarthritis , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[11]  K. Pavelka,et al.  Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis. , 2009, Osteoarthritis and cartilage.

[12]  A. Mobasheri,et al.  Targeting matrix metalloproteinases in inflammatory conditions. , 2009, Current drug targets.

[13]  Karsten Seeger,et al.  Metabolic changes in autoimmune diseases. , 2009, Current drug discovery technologies.

[14]  N. Oreiro,et al.  Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis , 2009, Annals of the rheumatic diseases.

[15]  F. Williams Biomarkers: in combination they may do better , 2009, Arthritis research & therapy.

[16]  S. Kiechl,et al.  Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints. , 2009, Arthritis and rheumatism.

[17]  H. Potter,et al.  Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. , 2009, Osteoarthritis and cartilage.

[18]  Mads Nielsen,et al.  Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers , 2009, Arthritis research & therapy.

[19]  S. Abramson,et al.  Developments in the scientific understanding of osteoarthritis , 2009, Arthritis research & therapy.

[20]  M. Karsdal,et al.  Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. , 2009, Osteoarthritis and cartilage.

[21]  K. Huang,et al.  YKL-40: A Potential Biomarker for Osteoarthritis , 2009, The Journal of international medical research.

[22]  A. Reddi,et al.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis , 2009, Biomarker insights.

[23]  S. Abramson,et al.  F-spondin , a neuroregulatory protein , is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-activation , 2009 .

[24]  V. Kraus,et al.  Variation in osteoarthritis biomarkers from activity not food consumption. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[25]  V. Kraus,et al.  Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study. , 2008, Osteoarthritis and cartilage.

[26]  E. Thonar,et al.  Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee. , 2008, Osteoarthritis and cartilage.

[27]  P. Kongtawelert,et al.  Evaluation of serum chondroitin sulfate and hyaluronan: biomarkers for osteoarthritis in canine hip dysplasia , 2008, Journal of veterinary science.

[28]  F. Eckstein,et al.  Imaging in osteoarthritis. , 2008, Rheumatic diseases clinics of North America.

[29]  Y Fujita,et al.  Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes , 2008, Annals of the rheumatic diseases.

[30]  P Kjaersgaard-Andersen,et al.  Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. , 2008, Osteoarthritis and cartilage.

[31]  S. Wakitani,et al.  Serum keratan sulfate is a promising marker of early articular cartilage breakdown. , 2007, Rheumatology.

[32]  Y. Henrotin,et al.  The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. , 2007, Arthritis and rheumatism.

[33]  Y. Henrotin,et al.  Type II collagen markers in osteoarthritis: what do they indicate? , 2007, Current opinion in rheumatology.

[34]  P. Delmas,et al.  Biological markers in osteoarthritis , 2007, Nature Clinical Practice Rheumatology.

[35]  Y. Henrotin,et al.  A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. , 2007, Research in veterinary science.

[36]  S. Goerdt,et al.  Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer , 2007, Biomarker insights.

[37]  N. Terada,et al.  Intraarticular injection of high molecular weight hyaluronan for osteoarthritis of the knee - prediction of effectiveness with biological markers. , 2006, The Journal of rheumatology.

[38]  A. Pitsillides,et al.  Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population. , 2006, Equine veterinary journal.

[39]  T. Cawston,et al.  Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. , 2006, Best practice & research. Clinical rheumatology.

[40]  Werner Zolg,et al.  The Proteomic Search for Diagnostic Biomarkers , 2006, Molecular & Cellular Proteomics.

[41]  J. Jordan,et al.  Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. , 2006, Arthritis and rheumatism.

[42]  D J Hunter,et al.  Classification of osteoarthritis biomarkers: a proposed approach. , 2006, Osteoarthritis and cartilage.

[43]  David I. Ellis,et al.  Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. , 2006, The Analyst.

[44]  S. Donell,et al.  Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage , 2006, Arthritis research & therapy.

[45]  N. Pejnović,et al.  Clinical significance of IL-18, IL-15, IL-12 and TNF-α measurement in rheumatoid arthritis , 2006, Clinical Rheumatology.

[46]  P. Sarzi-Puttini,et al.  Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others). , 2006, Rheumatic diseases clinics of North America.

[47]  F. Guilak,et al.  The Pericellular Matrix as a Transducer of Biomechanical and Biochemical Signals in Articular Cartilage , 2006, Annals of the New York Academy of Sciences.

[48]  T. Hardingham,et al.  Raised chondroitin sulfate epitopes and hyaluronan in serum from rheumatoid arthritis and osteoarthritis patients. , 2006, Osteoarthritis and cartilage.

[49]  C. Chichester,et al.  Review: Collagen markers in early arthritic diseases. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[50]  E. Thonar,et al.  Serum and synovial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritis following cranial cruciate ligament transection. , 2006, American journal of veterinary research.

[51]  K. Brandt,et al.  Urinary levels of type II collagen C-telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis , 2005, Annals of the rheumatic diseases.

[52]  Y. Henrotin,et al.  One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. , 2005, Osteoarthritis and cartilage.

[53]  C. Cooper,et al.  Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men , 2005, Annals of the rheumatic diseases.

[54]  J. Dudhia Aggrecan, aging and assembly in articular cartilage , 2005, Cellular and Molecular Life Sciences CMLS.

[55]  J. Jordan,et al.  Identification of an urinary metabolite profile associated with osteoarthritis. , 2005, Osteoarthritis and cartilage.

[56]  C. Pieper,et al.  Variation of serum hyaluronan with activity in individuals with knee osteoarthritis. , 2005, Osteoarthritis and cartilage.

[57]  V. Kraus Biomarkers in osteoarthritis , 2005, Current opinion in rheumatology.

[58]  Mukta Gupta,et al.  New frontiers in proteomics research: a perspective. , 2005, International journal of pharmaceutics.

[59]  J. Houwing-Duistermaat,et al.  Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study , 2005, Annals of the rheumatic diseases.

[60]  A. Zaninelli,et al.  Osteoarthritis: an overview of the disease and its treatment strategies. , 2005, Seminars in arthritis and rheumatism.

[61]  A. Mobasheri,et al.  Nutraceutical Therapies for Degenerative Joint Diseases: A Critical Review , 2005, Critical reviews in food science and nutrition.

[62]  M. Dougados,et al.  Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. , 2005, The Journal of rheumatology.

[63]  J. Reginster,et al.  New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. , 2005, Osteoarthritis and cartilage.

[64]  A. Poole,et al.  The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. , 2004, Journal of immunological methods.

[65]  D. Eyre,et al.  Collagens and cartilage matrix homeostasis. , 2004, Clinical orthopaedics and related research.

[66]  Joseph A Buckwalter,et al.  Sports and osteoarthritis , 2004, Current opinion in rheumatology.

[67]  J. Buckwalter,et al.  Aging theories of primary osteoarthritis: from epidemiology to molecular biology. , 2004, Rejuvenation research.

[68]  Carlos R Plata-Salamán,et al.  Biomarker discovery and validation: technologies and integrative approaches. , 2004, Trends in biotechnology.

[69]  A. Uitterlinden,et al.  A new marker for osteoarthritis: cross-sectional and longitudinal approach. , 2004, Arthritis and rheumatism.

[70]  P. Delmas,et al.  Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis , 2004, Annals of the rheumatic diseases.

[71]  J. Jordan Cartilage oligomeric matrix protein as a marker of osteoarthritis. , 2004, The Journal of rheumatology. Supplement.

[72]  K. Pavelka,et al.  Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. , 2004, Osteoarthritis and cartilage.

[73]  D. Salter,et al.  Integrin-Dependent Signal Cascades in Chondrocyte Mechanotransduction , 2004, Annals of Biomedical Engineering.

[74]  W. Richter,et al.  Increased Urinary Concentration of Collagen Type II C-Telopeptide Fragments in Patients with Osteoarthritis , 2004, Pathobiology.

[75]  D. Eyre,et al.  The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. , 2003, Arthritis and rheumatism.

[76]  L. Punzi,et al.  Laboratory investigations in osteoarthritis , 2003, Aging clinical and experimental research.

[77]  J. Buckwalter Sports, joint injury, and posttraumatic osteoarthritis. , 2003, The Journal of orthopaedic and sports physical therapy.

[78]  A. Zien,et al.  YKL-39 (chitinase 3-like protein 2), but not YKL-40 (chitinase 3-like protein 1), is up regulated in osteoarthritic chondrocytes , 2003, Annals of the rheumatic diseases.

[79]  E. Vignon,et al.  Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis , 2003, Annals of the rheumatic diseases.

[80]  P. Delmas,et al.  Biomarkers in osteoarthritis , 2003, Current opinion in rheumatology.

[81]  A. Poole,et al.  Proteolysis of the collagen fibril in osteoarthritis. , 2003, Biochemical Society symposium.

[82]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[83]  Olivier Ethgen,et al.  Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. , 2003, The Journal of rheumatology.

[84]  W. Richter,et al.  Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage. , 2002, Biochemical and biophysical research communications.

[85]  M. Dougados,et al.  Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. , 2002, Arthritis and rheumatism.

[86]  A. Mobasheri,et al.  INTEGRINS AND STRETCH ACTIVATED ION CHANNELS; PUTATIVE COMPONENTS OF FUNCTIONAL CELL SURFACE MECHANORECEPTORS IN ARTICULAR CHONDROCYTES , 2002, Cell biology international.

[87]  M. Adams,et al.  Serum YKL-40 is associated with osteoarthritis and atherosclerosis in nonhuman primates. , 2001, Clinical chemistry.

[88]  F Eckstein,et al.  Age-related changes in the morphology and deformational behavior of knee joint cartilage. , 2001, Arthritis and rheumatism.

[89]  P. Qvist,et al.  Collagen type II C-telopeptide fragments as an index of cartilage degradation. , 2001, Bone.

[90]  F. De Ceuninck,et al.  Development of an enzyme-linked immunoassay for the quantification of YKL-40 (cartilage gp-39) in guinea pig serum using hen egg yolk antibodies. , 2001, Journal of immunological methods.

[91]  E. Vignon,et al.  Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage , 2001, Annals of the rheumatic diseases.

[92]  A. Reginato,et al.  Familial calcium crystal diseases: what have we learned? , 2001, Current opinion in rheumatology.

[93]  M. Lotz,et al.  Regulation of YKL-40 production by human articular chondrocytes. , 2001, Arthritis and rheumatism.

[94]  K. Ostergaard,et al.  Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. , 2001, Osteoarthritis and cartilage.

[95]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[96]  Maximilian Reiser,et al.  In vivo morphometry and functional analysis of human articular cartilage with quantitative magnetic resonance imaging – from image to data, from data to theory , 2001, Anatomy and Embryology.

[97]  H. Iwata,et al.  Concentration and localization of YKL-40 in hip joint diseases. , 2001, The Journal of rheumatology.

[98]  Eric Lejeune,et al.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial , 2001, The Lancet.

[99]  E. Vignon,et al.  Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study , 2000, Annals of the rheumatic diseases.

[100]  C. Little,et al.  Mechanisms involved in cartilage proteoglycan catabolism. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[101]  F. Breedveld,et al.  Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions , 2000, Annals of the rheumatic diseases.

[102]  G. Illei,et al.  Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. , 2000, Arthritis and rheumatism.

[103]  J B Renner,et al.  Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. , 1999, Arthritis and rheumatism.

[104]  Poole Ar,et al.  An introduction to the pathophysiology of osteoarthritis. , 1999, Frontiers in bioscience : a journal and virtual library.

[105]  M. Shakibaei,et al.  Signal transduction by β1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor , 1999 .

[106]  R. Clancy Nitric oxide alters chondrocyte function by disrupting cytoskeletal signaling complexes. , 1999, Osteoarthritis and cartilage.

[107]  A. Poole,et al.  Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. , 1999, Arthritis and rheumatism.

[108]  Y. Hasegawa,et al.  Examination of synovial fluid and serum hyaluronidase activity as a joint marker in rheumatoid arthritis and osteoarthritis patients (by zymography) , 1999, Annals of the rheumatic diseases.

[109]  S. Jimenez,et al.  Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts. , 1998, Osteoarthritis and cartilage.

[110]  E. Vignon,et al.  Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study , 1998, Annals of the rheumatic diseases.

[111]  H. Iwata,et al.  Synovial fluid cartilage metabolism marker concentrations in osteonecrosis of the femoral head compared with osteoarthrosis of the hip. , 1998, The Journal of rheumatology.

[112]  Z. Werb ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.

[113]  J. Buckwalter,et al.  Athletics and Osteoarthritis , 1997, The American journal of sports medicine.

[114]  M. Paulsson,et al.  Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. , 1997, British journal of rheumatology.

[115]  D. Boettiger,et al.  Involvement of α5β1 Integrin in Matrix Interactions and Proliferation of Chondrocytes , 1997 .

[116]  J. Fraser,et al.  Hyaluronan: its nature, distribution, functions and turnover , 1997, Journal of internal medicine.

[117]  J. MacLeod,et al.  Cartilage fibronectin isoforms: in search of functions for a special population of matrix glycoproteins. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[118]  R. Loeser Growth factor regulation of chondrocyte integrins: Differential effects of insulin-like growth factor 1 and transforming growth factor β on α1β1 integrin expression and chondrocyte adhesion to type VI collagen , 1997 .

[119]  Y. Okada,et al.  Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.

[120]  T. Saxne,et al.  Cartilage markers in synovial fluid in symptomatic knee osteoarthritis , 1997, Annals of the rheumatic diseases.

[121]  M. Paulsson,et al.  Increased degradation and alteered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[122]  V. Backer,et al.  Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. , 1996, British journal of rheumatology.

[123]  C. López-Otín,et al.  Biochemical Characterization of Human Collagenase-3 (*) , 1996, The Journal of Biological Chemistry.

[124]  Helen Muir,et al.  The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[125]  E. Thonar,et al.  Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. , 1995, Arthritis and rheumatism.

[126]  P. Roughley,et al.  Cartilage proteoglycans: Structure and potential functions , 1994, Microscopy research and technique.

[127]  J. Ralphs,et al.  The joint capsule: structure, composition, ageing and disease. , 1994, Journal of anatomy.

[128]  John Calvin Reed,et al.  Anchorage dependence, integrins, and apoptosis , 1994, Cell.

[129]  E. Hunziker,et al.  Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. , 1994, The Journal of clinical investigation.

[130]  W. Puhl,et al.  Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. , 1993, Osteoarthritis and cartilage.

[131]  R. Davis,et al.  Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus , 1993, The Journal of cell biology.

[132]  D. Heinegård,et al.  Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. , 1992, British journal of rheumatology.

[133]  N. Maffulli,et al.  Effects of Physical Activity on Some Components of the Skeletal System , 1992, Sports medicine.

[134]  M. Tiku,et al.  Tripeptide RGD-dependent adhesion of articular chondrocytes to synovial fibroblasts. , 1992, Journal of cell science.

[135]  J. Isgaard Expression and regulation of IGF-I in cartilage and skeletal muscle. , 1992, Growth regulation.

[136]  E. Thonar,et al.  Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[137]  E. Thonar,et al.  Articular cartilage matrix and structure: a minireview. , 1991, The Journal of rheumatology. Supplement.

[138]  P. Kongtawelert,et al.  A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique. , 1990, Analytical biochemistry.

[139]  D. Heinegård,et al.  Chondrocyte-matrix interactions. Attachment to proteins isolated from cartilage. , 1989, Experimental cell research.

[140]  M. Yokoyama,et al.  Assay of serum hyaluronic acid in clinical application. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[141]  S. Lohmander Proteoglycans of joint cartilage. Structure, function, turnover and role as markers of joint disease. , 1988, Bailliere's clinical rheumatology.

[142]  H. Muir,et al.  Hyaluronic acid in human articular cartilage. Age-related changes in content and size. , 1988, The Biochemical journal.

[143]  M. Bayliss,et al.  Age-related changes in the composition and structure of human articular-cartilage proteoglycans. , 1978, The Biochemical journal.

[144]  Peter Müller,et al.  Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture , 1977, Nature.

[145]  R. Kosher,et al.  Stimulation of in vitro somite chondrogenesis by procollagen and collagen , 1975, Nature.

[146]  C. Sledge Structure, development, and function of joints. , 1975, The Orthopedic clinics of North America.

[147]  R. Minor,et al.  Environmental enhancement of in vitro chondrogenesis. IV. Stimulation of somite chondrogenesis by exogenous chondromucoprotein. , 1973, Developmental biology.

[148]  J. Johansen,et al.  YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. , 2009, Methods in molecular biology.

[149]  L. Ferrucci,et al.  Serum protein signatures detect early radiographic osteoarthritis. , 2009, Osteoarthritis and cartilage.

[150]  Dennis,et al.  An integrated omics analysis of eicosanoid biology. , 2009 .

[151]  D. Eyre,et al.  Biochemical Markers as Surrogate End Points of Joint Disease , 2008 .

[152]  C. Helmick,et al.  Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. , 2005, Arthritis and rheumatism.

[153]  M. Shinozaki,et al.  Quantitative analysis of hyaluronan in the synovial tissues of patients with joint disorders , 2005, Clinical Rheumatology.

[154]  J. Devogelaer,et al.  Comparative Effect of Nimesulide and Ibuprofen on the Urinary Levels of Collagen Type II C-Telopeptide Degradation Products and on the Serum Levels of Hyaluronan and Matrix Metalloproteinases-3 and -13 in Patients with Flare-Up of Osteoarthritis , 2005, Drugs in R&D.

[155]  J. Reginster,et al.  Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. , 2004, Clinical and experimental rheumatology.

[156]  E. Offord,et al.  Dietary supplementation with chondroitin sulfate and glucosamine HCL does not slow down articular cartilage erosion in biglycan/fibromodulin deficient mice , 2004 .

[157]  A. Mobasheri,et al.  Post-genomic applications of tissue microarrays: basic research, prognostic oncology, clinical genomics and drug discovery. , 2004, Histology and histopathology.

[158]  J. Reginster,et al.  Type II collagen peptides for measuring cartilage degradation. , 2004, Biorheology.

[159]  A. Woolf,et al.  Burden of major musculoskeletal conditions. , 2003, Bulletin of the World Health Organization.

[160]  A. Yee,et al.  Structure and function of aggrecan , 2002, Cell Research.

[161]  M. Tanzer,et al.  Aggrecan from start to finish , 2000, Journal of Bone and Mineral Metabolism.

[162]  K. Ostergaard,et al.  The distribution of YKL-40 in osteoarthritic and normal human articular cartilage. , 1999, Scandinavian journal of rheumatology.

[163]  V C Mow,et al.  Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration. , 1999, Osteoarthritis and cartilage.

[164]  H J Mankin,et al.  Articular cartilage: tissue design and chondrocyte-matrix interactions. , 1998, Instructional course lectures.

[165]  D. Heinegård,et al.  Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. , 1998, British journal of rheumatology.

[166]  R. Gay,et al.  Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury , 1998, Rheumatology International.

[167]  H J Mankin,et al.  Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. , 1998, Instructional course lectures.

[168]  Albert C. Chen,et al.  Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. , 1994, Archives of biochemistry and biophysics.

[169]  H. Mankin,et al.  Effect of Somatomedin-C/Insulin-Like Growth Factor I and Growth Hormone on Cultured Growth Plate and Articular Chondrocytes , 1989, Pediatric Research.

[170]  M. Silver,et al.  The role of chondronectin and cartilage proteoglycan in the attachment of chondrocytes to collagen. , 1982, Progress in clinical and biological research.

[171]  D. Dowson,et al.  The structure of joints. , 1973, International review of connective tissue research.

[172]  D. Hamerman,et al.  Structure and function of the synovial membrane. , 1966, Bulletin on the rheumatic diseases.